Full Text Article

Hip Fracture as the Presenting Feature of Celiac Disease: A Case Report

Received Date: April 19, 2021 Accepted Date: May 19, 2021 Published Date: May 22, 2021

doi: 10.17303/croa.2021.6.104

Citation: Mariam G (2021) Hip Fracture as the Presenting Feature of Celiac Disease: A Case Report. Case Reports: Open Access 6: 1-7.

A 38-year-old woman presented to explore the etiology of hip fracture after a slight fall. Bone mineral density showed bone demineralization and laboratory investigations were in favor of osteomalacia. Serological markers for CD were highly positive: IgA anti-endomysial antibodies (indirect immunofluorescence)+++, IgA anti-transglutaminase 2 antibodies (ELISA) = 144 RU/ml, IgA anti-deaminated gliadine peptides antibodies (ELISA)  >200 RU/ml, IgG anti-deaminated gliadine peptides (ELISA) 118 RU/ml. Diagnosis of osteomalacia secondary to longstanding undiagnosed celiac disease was made. Calcium, vitamin D and iron supplementation was prescribed and gluten free diet was started.

Keywords: Celiac Disease; Osteomalacia; Hip Fracture

Celiac disease (CD), a systemic auto-immune disease, is driven by dietary gluten in genetically predisposed subjects. CD is more common in females. This disorder could be accompanied by gastrointestinal or extra intestinal symptoms; it can even remain asymptomatic. Several complications can occur due to undiagnosed or untreated CD. It is often associated with more or less severe malabsorption syndrome responsible for nutritional deficiencies including vitamin D, calcium and phosphorus [1].

Low levels of vitamin D, calcium and phosphorus could cause bone demineralization and osteomalacia [2]. In this paper, we will present a patient with severe osteomalacia due to longstanding undiagnosed CD.

A 38-years-old female was admitted to rheumatology department to explore the etiology of hip fracture after a slight fall for which she was operated.

On examination, the patient was small and underweight; her weight was 39 Kg and her height was 149 cm (Body Mass Index = 17,56 Kg/m2). She had pale conjunctive. The direct inquiry revealed that she had three spontaneous miscarriages and anemia not corrected by oral iron supplementation.

Bone mineral density showed bone demineralization (low density at both lumbar vertebra L1-L4 = -5DS and femoral neck = -4,8 DS; Tscore = -5, Z score = -4).

On laboratory evaluation, increased alkaline phosphatase, low 25 hydroxyvitamin D (25(OH) D), low calcium and low phosphate values were all in favor of osteomalacia. Table 1 shows the result of phosphocalcic metabolism.

All serological markers for CD were highly positive: IgA anti-endomysial antibodies (indirect immunofluorescence)+++, IgA anti-transglutaminase 2 antibodies (ELISA) = 144 RU/ml (NV<25 RU/ml), IgA anti-deaminated gliadine peptides antibodies (ELISA)  >200 RU/ml (NV<25 RU/ml), IgG anti-deaminated gliadine peptides (ELISA) 118 RU/ml (NV<25 RU/ml).

Antinuclear antibodies, anti-cardiolipin antibodies, anti β2-glycoprotein I antibodies, anti-thyroid antibodies, anti-cyclic citrullinated peptide antibodies and rheumatoid factors were all negative.

Biochemistry and hematology parameters are indicated in Table 2.

Protein electrophoresis was normal.

The diagnosis of osteomalacia due to untreated CD was made.

Calcium, vitamin D and iron supplementation was prescribed and a gluten free diet was started.

The association CD-osteomalacia was mostly described as case reports [3,9]. In aIl these cases osteomalacia was revealed by bone pain or weakness. None of the patients had, like our patient's case, a severe fracture.  Only Tahiri el al reported a double symptomatic fracture of the wirst and femur in a 36-year old woman [8].

Osteomalacia results from defective mineralization when the body is prived from calcium and vitamin D [2]. This disease occurs when existing bone is replaced by unmineralized bone matrix or when newly formed bone is not mineralized [2]. CD, which is the first cause of malabsorption syndrome, could be the cause of osteomalacia. In our patient, the diagnosis of CD was made regarding the positivity of serological markers. In fact, it has been recently demonstrated that bowel biopsy is not always required to diagnose CD in patient with concordant antibody results [10,11].

The arthralgia and myalgia from which suffer our patient could also due to her untreated CD. In fact, celiac disease is significantly more frequent in patients with unexplained articular manifestations than in general population [12] and the cause-effect relation was proved by a complete remission after starting gluten free diet [13,14]. In our previous study about the frequency of CD in patients with unexplained articular manifestations, an 80-years-old woman was admitted to the hospital for arthralgia and her medical records revealed that she had one abortion and 8 children died before the age of 6 months.

Our patient had three spontaneous miscarriages. It is well known that CD increases the risk of recurrent miscarriages. During CD, there is production of anti-endomysium and anti-transglutaminase 2. The transglutaminase 2 (TG2), the main autoantigen of CD, is an ubiquitous enzyme and so expressed in endometrial cells, stromal and trophoblast placental cells. Maternal CD antibodies binding the placental TG2 may adversely affect placental function. In fact, they could cause an inhibition of syncytial TG2 impairing placental development and endometrial angiogenesis [15,16]. It was also demonstrated that spontaneous abortions in CD patients has been linked to vitamin and mineral deficiencies [15].   

Our patient had moderate hypertransaminasemia probably due to untreated celiac disease. In fact, we and others [17,18] demonstrated that 9% of patients with unexplained liver cytolysis had CD. In CD, The increase of transaminases levels was mild [19] and the elevated levels reverted to normal in the majority of patients on strict gluten free diet [18]. Several mechanisms were involved in liver damage [19] especially the chronic intestinal inflammation causing an exposure of TG2. The autoantibodies produced during CD could reach TG2 in extra-intestinal tissues and play an important part in liver injury. Furthermore, the increased intestinal permeability induced by gliadin cause an exposure, of the hepatobiliary system, to toxins and antigens and to proinflammatory cytokines. The malabsorption and the bacterial overgrowth observed in CD have been also suggested as possible mechanisms of liver injury in CD [19].

Celiac disease is a frequent cause of hematologic disorders. Our patient’s haemoglobin was 8.9 g/dl despite iron supplementation. The anemia was due to an iron malabsorption, in fact, iron and ferritin levels were decreased. Anemia is the most frequent non gastro-intestinal manifestation of CD [20]. Our team described three cases of severe osteomalacia presenting as a major feature of CD [3]. All of them had anemia and one of these patients had a 15-years history of persistent iron-deficiency anemia despite oral iron supplementation.

The leukopenia, in our patient was probably due to reduced level of folic-acid. Indeed, severe folic-acid deficiency can result in a decrease in both leukocytes and platelets and even manifest as severe pancytopenia [20].

Within one year after starting the gluten free diet, levels of liver enzymes, calcium and phosphorus reverted to normal and arthralgia and myalgia disappeared.

This case repot highlights, once more, the importance to be aware of the predominance of extraintestinal manifestations in CD, because a very late diagnosis can lead to serious complications which can go as far as a severe fracture of the hip.

Mariam Ghozzi and Skander Laabidi did Immunological tests and wrote the manuscript; Sawssen Mrad did Biochemistry analyses; Khadija Baccouch and Elyes Bouajina did clinical investigations and revised the manuscript.

  1. Sulimani RA (2019) Celiac disease and severe vitamin D deficiency: the case for anti-tissue transglutaminase antibody screening. Arch Osteoporosis 14: 30.
  2. Uday S, Högler W (2019) Spot the silent sufferers: A call for clinical diagnostic criteria for solar and nutritional osteomalacia, J Steroid Biochem Mol Biol 188: 141-46.
  3. Landolsi H, Bouajina E, Mankaï A, Zeglaoui H, Skandrani K, et al. (2006) Severe osteomalacia due to undiagnosed coeliac disease: three case reports of Tunisian women. Rheumatol Int 26: 261-3.
  4. Harzy T, Benbouazza K, Amine B, Rahmouni R, Hajjaj-Hassouni N (2005) An unusual case of osteomalacia as the presenting feature of coeliac disease. Rheumatol Int 26: 90-1.
  5. Albany C, Servetnyk Z (2009) Disabling osteomalacia and myopathy as the only presenting features of celiac disease: a case report. Cases J 2: 20.
  6. Sahebari M, Sigari SY, Heidari H, Biglarian O (2011) Osteomalacia can still be a point of attention to celiac disease. Clin Cases Miner Bone Metab 8:14-5.
  7. Rabelink NM, Westgeest HM, Bravenboer N, Jacobs MA, Lips P (2011) Bone pain and extremely low bone mineral density due to severe vitamin D deficiency in celiac disease. Arch Osteoporosis 6: 209-13.
  8. Tahiri L, Azzouzi H, Squalli G, Abourazzak F, Harzy T (2014) Celiac disease causing severe osteomalacia: an association still present in Morocco! Pan Afr Med J 19: 43.
  9. Selek O, Memisoglu K, Selek A (2015) Bilateral femoral neck fatigue fracture due to osteomalacia secondary to celiac disease: Report of three cases. Arch Iran Med 18: 542-4.
  10. Holmes GKT , Forsyth JM, Knowles S, Seddon H, PG Hill, et al. (2017) Coeliac disease: further evidence that biopsy is not always necessary for diagnosi, Eur J Gastroenterol Hepatol 29: 640-645.
  11. Husby S, Murray JA, Katzka DA (2019) AGA clinical practice update on diagnosis and monitoring of celiac disease-changing utility of serology and histologic measures: Expert Review Gastroenterology 156: 885-89.
  12. Ghozzi M, Sakly W, Mankai A, Bouajina E, Bahri F, et al. (2014) Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations. Rheumatol Int 34: 637-42.
  13. Hepburn AL, Kaye SA (2001) Oligoarthritis in an elderly woman with diarrhoea and weight loss. Postgraduate Med J 77: 475-7.
  14. Borg AA, Dawes PT, Swan CH, Hothersall TE (1994) Persistent monoarthritis and occult coeliac disease. Postgraduate Med J 70: 51-3.
  15. Casella G, Orfanotti G, Giacomantonio L, Bella CD, Crisafulli V, et al. (2016) Celiac disease and obstetrical-gynecological contribution. Gastroenterol Hepatol Bed Bench 9: 241-49.
  16. Di Simone N, Silano M, Castellani R, Di Nicuolo F, D’Alessio M C, et al. (2010) Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro. Am J Gastroenterol 105: 2254-61. 
  17. Ghozzi M, Ben Salem MA, Mbarki F, Jmaa A, Baccouch A, et al. (2017) Screening for celiac disease, by endomysial antibodies, in patients with unexplained hypertransaminasaemia. Scand J Clin Lab Invest 77: 454-57.
  18. Volta U, Granito A, De Franceschi L, Petrolini N, Bianchi FB. Anti-tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis 33: 420-5.
  19. Volta U (2009) Pathogenesis and clinical significance of liver injury in celiac disease. Clin Rev Allergy Immunol 36: 62-70.
  20. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease, Blood 109: 412-21.
CommentsTable 1 CommentsTable 2